These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35218991)

  • 1. Diagnostic performance of two serological assays for the detection of SARS-CoV-2 specific antibodies: surveillance after vaccination.
    Fresco-Taboada A; García-Durán M; Aira C; López L; Sastre P; van der Hoek L; van Gils MJ; Brouwer PJM; Sanders RW; Holzer B; Zimpernikc I; López-Collazo E; Muñoz P; Rueda P; Vela C
    Diagn Microbiol Infect Dis; 2022 Apr; 102(4):115650. PubMed ID: 35218991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Antibody Rapid Tests: Valuable Epidemiological Tools in Challenging Settings.
    Saluzzo F; Mantegani P; Poletti De Chaurand V; Quaresima V; Cugnata F; Di Serio C; Macé A; De Vos M; Sacks JA; Cirillo DM
    Microbiol Spectr; 2021 Oct; 9(2):e0025021. PubMed ID: 34549999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response.
    Mahmoud SA; Ganesan S; Naik S; Bissar S; Zamel IA; Warren KN; Zaher WA; Khan G
    Microbiol Spectr; 2021 Oct; 9(2):e0073321. PubMed ID: 34585943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers.
    Irsara C; Egger AE; Prokop W; Nairz M; Loacker L; Sahanic S; Pizzini A; Sonnweber T; Holzer B; Mayer W; Schennach H; Loeffler-Ragg J; Bellmann-Weiler R; Hartmann B; Tancevski I; Weiss G; Binder CJ; Anliker M; Griesmacher A; Hoermann G
    Clin Chem Lab Med; 2021 Jul; 59(8):1453-1462. PubMed ID: 33837679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study.
    Horn MP; Jonsdottir HR; Brigger D; Damonti L; Suter-Riniker F; Endrich O; Froehlich TK; Fiedler M; Largiadèr CR; Marschall J; Weber B; Eggel A; Nagler M
    Allergy; 2022 Jul; 77(7):2090-2103. PubMed ID: 34986501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans.
    Forgacs D; Jang H; Abreu RB; Hanley HB; Gattiker JL; Jefferson AM; Ross TM
    Front Immunol; 2021; 12():728021. PubMed ID: 34646267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?
    van den Hoogen LL; Smits G; van Hagen CCE; Wong D; Vos ERA; van Boven M; de Melker HE; van Vliet J; Kuijer M; Woudstra L; Wijmenga-Monsuur AJ; GeurtsvanKessel CH; Stoof SP; Reukers D; Wijsman LA; Meijer A; Reusken CBEM; Rots NY; van der Klis FRM; van Binnendijk RS; den Hartog G
    Vaccine; 2022 Apr; 40(15):2251-2257. PubMed ID: 35287986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
    Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of rapid antigen test prototype for detection of SARS-CoV-2 in saliva samples.
    Kivrane A; Igumnova V; Liepina EE; Skrastina D; Leonciks A; Rudevica Z; Kistkins S; Reinis A; Zilde A; Kazaks A; Ranka R
    Ups J Med Sci; 2022; 127():. PubMed ID: 35284045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.
    Chen GL; Li XF; Dai XH; Li N; Cheng ML; Huang Z; Shen J; Ge YH; Shen ZW; Deng YQ; Yang SY; Zhao H; Zhang NN; Zhang YF; Wei L; Wu KQ; Zhu MF; Peng CG; Jiang Q; Cao SC; Li YH; Zhao DH; Wu XH; Ni L; Shen HH; Dong C; Ying B; Sheng GP; Qin CF; Gao HN; Li LJ
    Lancet Microbe; 2022 Mar; 3(3):e193-e202. PubMed ID: 35098177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.
    Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y
    Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of laboratory developed serology assays for detection of IgG antibody to severe acute respiratory syndrome coronavirus 2 in the South African population.
    Matefo L; Cloete VV; Armand BP; Dominique G; Samantha P; John F; Craig T; Daniel W; Theresa L; Sunetra G; Maréza B; Danelle VJ; Jane BF
    J Virol Methods; 2022 Sep; 307():114571. PubMed ID: 35750222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
    McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays.
    Chapuy-Regaud S; Miédougé M; Abravanel F; Da Silva I; Porcheron M; Fillaux J; Diméglio C; Izopet J
    Microbiol Spectr; 2021 Dec; 9(3):e0137621. PubMed ID: 34937195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A urine-based ELISA with recombinant non-glycosylated SARS-CoV-2 spike protein for detecting anti-SARS-CoV-2 spike antibodies.
    Ramos FF; Bagno FF; Vassallo PF; Oliveira-da-Silva JA; Reis TAR; Bandeira RS; Machado AS; Lage DP; Martins VT; Fernandes AP; Christodoulides M; Ravetti CG; Nobre V; da Fonseca FG; Coelho EAF; Ludolf F
    Sci Rep; 2023 Mar; 13(1):4345. PubMed ID: 36927952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rapid, point-of-care red blood cell agglutination assay detecting antibodies against SARS-CoV-2.
    Kruse RL; Huang Y; Smetana H; Gehrie EA; Amukele TK; Tobian AAR; Mostafa HH; Wang ZZ
    Biochem Biophys Res Commun; 2021 May; 553():165-171. PubMed ID: 33773139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid Quantitative Point-Of-Care Diagnostic Test for Post COVID-19 Vaccination Antibody Monitoring.
    Moeller ME; Engsig FN; Bade M; Fock J; Pah P; Soerensen AL; Bang D; Donolato M; Benfield T
    Microbiol Spectr; 2022 Apr; 10(2):e0039622. PubMed ID: 35357223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination.
    Kenny G; Negi R; O'Reilly S; Garcia-Leon A; Alalwan D; Gaillard CM; Saini G; Inzitari R; Feeney ER; Yousif O; Cotter AG; de Barra E; Sadlier C; Crispie F; Doran P; Gautier V; Mallon PWG;
    J Immunol Methods; 2022 Nov; 510():113345. PubMed ID: 36055441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays.
    Valcourt EJ; Manguiat K; Robinson A; Lin YC; Abe KT; Mubareka S; Shigayeva A; Zhong Z; Girardin RC; DuPuis A; Payne A; McDonough K; Wang Z; Gasser R; Laumaea A; Benlarbi M; Richard J; Prévost J; Anand SP; Dimitrova K; Phillipson C; McGeer A; Gingras AC; Liang C; Petric M; Sekirov I; Morshed M; Finzi A; Drebot M; Wood H
    Microbiol Spectr; 2021 Dec; 9(3):e0088621. PubMed ID: 34787495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests.
    De Marco Verissimo C; O'Brien C; López Corrales J; Dorey A; Cwiklinski K; Lalor R; Doyle JM; Field S; Masterson C; Ribes Martinez E; Hughes G; Bergin C; Walshe K; McNicholas B; Laffey JG; Dalton JP; Kerr C; Doyle S
    Epidemiol Infect; 2021 Jun; 149():e140. PubMed ID: 34099081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.